Drug intelligence / Profile preview

halazepam

Development stage
Discontinued
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Halazepam is a benzodiazepine derivative that was used primarily as an anxiolytic to relieve anxiety, nervousness, and tension associated with anxiety disorders. It exerts its effects by acting as a positive allosteric modulator of the GABA(A) receptor complex in the central nervous system, enhancing the inhibitory effect of gamma-aminobutyric acid (GABA). Halazepam also has anticonvulsant, sedative, and muscle relaxant properties. It was considered less toxic than chlordiazepoxide or diazepam. The drug was invented by Schlesinger Walter in the United States and marketed from 1981 under various brand names including Paxipam (US), Alapryl (Spain), and Pacinone (Portugal). However, it is no longer commercially available in the United States after being withdrawn for poor sales by its manufacturer Schering in 2009[2][4][7].

Brand names
PaxipamAlaprylPacinone
Other names
halazepam
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on halazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on halazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call